Alcide Barberis
Direktor/Vorstandsmitglied bei EffRx Pharmaceuticals SA
Ursprung des Netzwerks ersten Grades von Alcide Barberis
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Telormedix SA
 Telormedix SA Pharmaceuticals: MajorHealth Technology Telormedix SA operates as a biopharmaceutical company, that focuses on targeted immunity in the treatment of cancer and other diseases. Its products include TMX-101 for the treatment of localized bladder cancer, TMX-201 for the topical treatment of bladder cancer, skin cancer, and other indications, as well as for use as a vaccine adjuvant, and TMX-302 for use in preclinical trials for the treatment of autoimmune disease. The company was founded in October 2007 by Lorenzo Leoni, Roberto Maj, Rolf M. Zinkernagel and Dennis A. Carson and is headquartered in Lugano, Switzerland.
6
| Extinct | Pharmaceuticals: Major | 6 |
EffRx Pharmaceuticals SA
 EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology EffRx Pharmaceuticals SA manufactures and distributes specialty pharmaceutical products. The firm's focus areas include metabolic bone disease, oncology supportive care, pediatric medication, and medical support to companies in life cycle management. It also engages in licensing agreements and distribution and commercialization partnerships. The company was founded by Christer Ros?n in 1998 and is headquartered in Freienbach, Switzerland.
5
| Holding Company | Pharmaceuticals: Other | 5 |
Oncalis AG
 Oncalis AG Pharmaceuticals: MajorHealth Technology Oncalis AG ('Oncology alliances') has been founded in June 2006 as a spin-off from ESBATech AG, a Swiss biotechnology company that has developed technology platforms in both the antibody and small molecule areas of pharmaceutical research. Oncalis has acquired from the mother company all small molecule-related assets, including a yeast-cell based, high- throughput screening platform for receptor tyrosine kinases (RTKs), and a number of specific and potent kinase inhibitors. The company is currently financed by ESBATech's Series A investors, including Novartis Venture Fund, BioMedInvest and Venture Incubator (VI) Partners. Oncalis will now focus on the discovery and development of small molecule inhibitors for oncology indications.
4
| Extinct | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Alcide Barberis
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Stockholm | College/University | Graduate Degree Undergraduate Degree | |
| Pergasus AB | Director/Board Member Director/Board Member | ||
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Pergamum AB
 Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Corporate Secretary | |
| MINESTO AB | Alternative Power Generation | Director/Board Member | |
| MOBERG PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Midroc New Technology AB
 Midroc New Technology AB Investment ManagersFinance (Midroc New Technology AB) Mid-Atlantic Venture Funds is a venture capital firm founded in 1984. Mid-Atlantic Venture Funds is headquartered in Sundbyberg. | Investment Managers | Chief Executive Officer | |
TranSiC AB
 TranSiC AB SemiconductorsElectronic Technology TranSiC AB designs and manufactures silicon carbide transistors. It develops Bipolar Junction power Transistors (BJT's) manufactured in the semiconductor material of silicon carbide. The company was founded by Martin Domeij, Mikael Östling and Bo Hammarlund in Decemeber 2005 and is headquartered in Kista, Sweden. | Semiconductors | Director/Board Member | |
| Royal Institute of Technology | College/University | Graduate Degree | |
Jensen Devices AB
 Jensen Devices AB Electronic Production EquipmentElectronic Technology Jensen Devices AB manufactures and sells electronic components. It focuses on lighting system, lamps, and fluorescents. The company was founded on January 25, 2001 and is headquartered in Saltsjö-Duvnäs, Sweden. | Electronic Production Equipment | Director/Board Member | |
| NILSSON SPECIAL VEHICLES AB | Motor Vehicles | Director/Board Member | |
| Airgrinder AB | Director/Board Member | ||
| M & J by Malin & Johanna AB | Director/Board Member | ||
| CRUNCHFISH AB | Packaged Software | Chairman | |
| POWERCELL SWEDEN AB | Alternative Power Generation | Director/Board Member | |
| USC School of Pharmacy | College/University | Doctorate Degree | |
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
| UCLA Institute of Urologic Oncology | Director/Board Member | ||
| David Geffen School of Medicine | College/University | Corporate Officer/Principal | |
| University of Uppsala | College/University | Corporate Officer/Principal | |
| Invitrogen AB | Corporate Officer/Principal | ||
| The Releef Initiative | Director/Board Member | ||
Sequenom GmbH
 Sequenom GmbH Medical SpecialtiesHealth Technology Part of Laboratory Corp. of America Holdings, Sequenom GmbH is a German company that manufactures computer applications and technology systems for the diagnostic of genomic sciences. The company is based in Hamburg, Germany. | Medical Specialties | Corporate Officer/Principal | |
| COMBIGENE AB | Pharmaceuticals: Major | Chairman | |
| World 5 Ventures | Director/Board Member | ||
| Edge of The World Strategies Corp. | President | ||
Corespring Invest AB
 Corespring Invest AB Miscellaneous Commercial ServicesCommercial Services Part of Midroc Europe AB, Corespring Invest AB provides business management and consulting services. The company is based in Sundbyberg, Sweden. Göran Harald Linder has been the CEO of the Swedish company since 2006. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Minesto Warrants One AB | Director/Board Member | ||
SolarWave AB
 SolarWave AB Industrial MachineryProducer Manufacturing SolarWave AB provides solar powered water purification and desalination systems. Its products include SolarWave Backpacker, SolarWave PB1000, SolarWave WP360 School and SolarWave WP700 II. The firm offers supporting solutions such as solar driven water purification systems and desalination systems. The company was founded in 2009 by Anders Kanhov, Bengt Skörelid and Thomas Larsson and is headquartered in Gävle, Sweden. | Industrial Machinery | Director/Board Member | |
IBSA Institut Biochimique SA
 IBSA Institut Biochimique SA Pharmaceuticals: MajorHealth Technology IBSA Institut Biochimique SA manufactures pharmaceutical preparations such as topical creams and pads, painkiller drugs, hormone preparations. The company was founded by Arturo Licenziati in 1945 and is headquartered in Montagnola, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Brane Discovery SRL | Corporate Officer/Principal | ||
| University of Warsaw | College/University | Graduate Degree | |
Kupando GmbH
 Kupando GmbH BiotechnologyHealth Technology Kupando GmbH is a German biopharmaceutical company that develops agonists to stimulate innate immunity. The company is based in Schoenefeld, Germany. The company was founded in 2018 by Johanna Holldack, who has been the CEO since 2018. | Biotechnology | Chief Operating Officer |
Statistik
International
| Schweden | 29 |
| Vereinigte Staaten | 11 |
| Schweiz | 7 |
| Deutschland | 3 |
| Italien | 3 |
Sektoral
| Health Technology | 18 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Electronic Technology | 4 |
| Producer Manufacturing | 4 |
Operativ
| Director/Board Member | 82 |
| Corporate Officer/Principal | 54 |
| Chief Executive Officer | 14 |
| Founder | 14 |
| Chairman | 11 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Göran Harald Linder | 37 |
| Anders Paul Wiklund | 29 |
| Dennis A. Carson | 21 |
| Jonas Göran Ekblom | 21 |
| Arnd Kaltofen-Ehmann | 16 |
| Stuart Holden | 16 |
| Rolf M. Zinkernagel | 10 |
| Roberto Maj | 7 |
| Lorenzo Bosisio | 7 |
| Raffaella Pozzi | 5 |
| Adrian Escher | 4 |
| Hans-Georg Capraro | 4 |
| Phillipe Lutz | 3 |
| Peter Traxler | 2 |
| Josef Hruska | 1 |
- Börse
- Insiders
- Alcide Barberis
- Unternehmensverbindungen
